Yüklüyor......
Challenges for drug discovery - a case study of urokinase receptor inhibition
Urokinase receptor (uPAR) is a widely recognized target for potential treatment of cancer. The development of uPAR inhibitors has been going on for over a decade. Despite the identification and validation of many highly potent hits using screening or medicinal approaches, none of them has been moved...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2797710/ https://ncbi.nlm.nih.gov/pubmed/20025562 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|